FDA Recalls Rapidol Arnica Gel Due to Manufacturing Quality Deviations
The FDA has recalled Rapidol Arnica Gel, a topical homeopathic medicine, due to deviations from good manufacturing practices. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This recall receives a Moderate rating due to being voluntary and precautionary with no reported illnesses or injuries. Per the severity rubric, voluntary precautionary recalls are classified as Score 2.
Plain-English summary
Pharmadel, LLC has recalled Rapidol Arnica Gel, a topical homeopathic medicine distributed in Delaware. The recall involves 6,048 bottles of the 2 oz (57 g) product with lot number EAG-01 and expiration date March 27 (NDC 55758-403-02).
The recall was initiated due to deviations from current Good Manufacturing Practice (cGMP) standards discovered during manufacturing. Pharmadel voluntarily initiated the recall in April 2025.
Consumers who possess this product should discontinue use and consult a healthcare provider with any concerns about exposure.
The recalled product
- Product
- Rapidol Arnica Gel, Topical Gel, Homeopathic Medicine, 2 oz (57 g), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-403-02
- Manufacturer
- Pharmadel, LLC
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot
- expiry: EAG-01
- EXP: MAR 27
Distribution
Distributed in 1 state:
- DE
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27